| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |